Table: RaQualia Pharma -2023 parent results

RaQualia Pharma

14/02/2024 06:30

Feb 14 (Reuters)- 
          RaQualia Pharma Inc 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Dec 31, 2023    Dec 31, 2022   Dec 31, 2024     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             1.64            2.68                                 
                 (-38.7 pct)     (+13.5 pct)                             
  Operating     loss 478 mln       683 mln                               
                                 (+35.1 pct)                             
  Recurring     loss 444 mln       701 mln                               
                                 (+6.9 pct)                              
  Net           loss 431 mln       583 mln                               
                                 (-5.1 pct)                              
  EPS          loss 19.95 yen     27.83 yen                              
  EPS Diluted                     27.81 yen                              
  Ann Div            NIL             NIL            NIL                  
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div            NIL             NIL            NIL                  
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T